Becker Muscular Dystrophy Medication

1. Becker PE, Kiener F. [A new x-chromosomal muscular dystrophy.]. Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr. 1955. 193(4):427-48. [QxMD MEDLINE Link].

2. Becker PE. Two families of benign sex-linked recessive muscular dystrophy. Rev Can Biol. 1962 Sep-Dec. 21:551-66. [QxMD MEDLINE Link].

3. Andrews JG, Wahl RA. Duchenne and Becker muscular dystrophy in adolescents: current perspectives. Adolesc Health Med Ther. 2018. 9:53-63. [QxMD MEDLINE Link]. [Full Text].

4. Thada PK, Bhandari J, Umapathi KK. Becker Muscular Dystrophy. StatPearls. 2023 Jul 19. [QxMD MEDLINE Link]. [Full Text].

5. Straub V, Guglieri M. An update on Becker muscular dystrophy. Curr Opin Neurol. 2023 Oct 1. 36 (5):450-4. [QxMD MEDLINE Link]. [Full Text].

6. Angelini C, Fanin M, Pegoraro E, et al. Clinical-molecular correlation in 104 mild X-linked muscular dystrophy patients: characterization of sub-clinical phenotypes. Neuromuscul Disord. 1994 Jul. 4(4):349-58. [QxMD MEDLINE Link].

7. Gurvich OL, Tuohy TM, Howard MT, et al. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy. Ann Neurol. 2008 Jan. 63(1):81-9. [QxMD MEDLINE Link].

8. Ashton EJ, Yau SC, Deans ZC, et al. Simultaneous mutation scanning for gross deletions, duplications and point mutations in the DMD gene. Eur J Hum Genet. 2008 Jan. 16(1):53-61. [QxMD MEDLINE Link].

9. Arahata K, Beggs AH, Honda H, et al. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy. J Neurol Sci. 1991 Feb. 101(2):148-56. [QxMD MEDLINE Link].

10. Koenig M, Beggs AH, Moyer M, et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet. 1989 Oct. 45(4):498-506. [QxMD MEDLINE Link]. [Full Text].

11. Schwartz M, Hertz JM, Sveen ML, et al. LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype. Neurology. 2005 May 10. 64(9):1635-7. [QxMD MEDLINE Link].

12. Cirak S, Feng L, Anthony K, Arechavala-Gomeza V, Torelli S, Sewry C, et al. Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy. Mol Ther. 2011 Nov 15. [QxMD MEDLINE Link].

13. Mavrogeni S, Markousis-Mavrogenis G, Papavasiliou A, Kolovou G. Cardiac involvement in Duchenne and Becker muscular dystrophy. World J Cardiol. 2015 Jul 26. 7 (7):410-4. [QxMD MEDLINE Link].

14. Nicolas A, Raguenes-Nicol C, Ben Yaou R, et al. Becker muscular dystrophy severity is linked to the structure of dystrophin. Hum Mol Genet. 2015 Mar 1. 24 (5):1267-79. [QxMD MEDLINE Link].

15. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics. 2005 Dec. 116(6):1569-73. [QxMD MEDLINE Link]. [Full Text].

16. Emery AE, Skinner R. Clinical studies in benign (Becker type) X-linked muscular dystrophy. Clin Genet. 1976 Oct. 10(4):189-201. [QxMD MEDLINE Link].

17. Holloway SM, Wilcox DE, Wilcox A, et al. Life expectancy and death from cardiomyopathy amongst carriers of Duchenne and Becker muscular dystrophy in Scotland. Heart. 2007 Oct 11. [QxMD MEDLINE Link].

18. Young HK, Barton BA, Waisbren S, et al. Cognitive and Psychological Profile of Males With Becker Muscular Dystrophy. J Child Neurol. 2007 Dec 3. [QxMD MEDLINE Link].

19. De Wel B, Willaert S, Nadaj-Pakleza A, et al. Respiratory decline in adult patients with Becker muscular dystrophy: a longitudinal study. Neuromuscul Disord. 2020 Dec 26. [QxMD MEDLINE Link].

20. Zhang H, Zhu Y, Sun Y, et al. Serum creatinine level: a supplemental index to distinguish Duchenne muscular dystrophy from Becker muscular dystrophy. Dis Markers. 2015. 2015:141856. [QxMD MEDLINE Link].

21. Menezes MP, North KN. Inherited neuromuscular disorders: Pathway to diagnosis. J Paediatr Child Health. 2011 Nov 3. [QxMD MEDLINE Link].

22. Lim BC, Lee S, Shin JY, Kim JI, Hwang H, Kim KJ, et al. Genetic diagnosis of Duchenne and Becker muscular dystrophy using next-generation sequencing technology: comprehensive mutational search in a single platform. J Med Genet. 2011 Nov. 48(11):731-6. [QxMD MEDLINE Link].

23. Marty B, Gilles R, Toussaint M, et al. Comprehensive evaluation of structural and functional myocardial impairments in Becker muscular dystrophy using quantitative cardiac magnetic resonance imaging. Eur Heart J Cardiovasc Imaging. 2018 Dec 24. [QxMD MEDLINE Link].

24. Rutkove SB, Darras BT. Electrical impedance myography for the assessment of children with muscular dystrophy: a preliminary study. J Phys Conf Ser. 2013. 434(1):[QxMD MEDLINE Link]. [Full Text].

25. Magot A, Wahbi K, Leturcq F, et al. Diagnosis and management of Becker muscular dystrophy: the French guidelines. J Neurol. 2023 Oct. 270 (10):4763-81. [QxMD MEDLINE Link]. [Full Text].

26. Grootenhuis MA, de Boone J, van der Kooi AJ. Living with muscular dystrophy: health related quality of life consequences for children and adults. Health Qual Life Outcomes. 2007. 5:31. [QxMD MEDLINE Link]. [Full Text].

27. Yamada Y, Kawakami M, Wada A, Otsuka T, Muraoka K, Liu M. A comparison of swallowing dysfunction in Becker muscular dystrophy and Duchenne muscular dystrophy. Disabil Rehabil. 2017 Mar 13. 1-5. [QxMD MEDLINE Link].

28. Hayes J, Veyckemans F, Bissonnette B. Duchenne muscular dystrophy: an old anesthesia problem revisited. Paediatr Anaesth. 2008 Feb. 18(2):100-6. [QxMD MEDLINE Link].

29. Segura LG, Lorenz JD, Weingarten TN, Scavonetto F, Bojanic K, Selcen D, et al. Anesthesia and Duchenne or Becker muscular dystrophy: review of 117 anesthetic exposures. Paediatr Anaesth. 2013 Sep. 23(9):855-64. [QxMD MEDLINE Link].

30. Jenkins HM, Stocki A, Kriellaars D, Pasterkamp H. Breath stacking in children with neuromuscular disorders. Pediatr Pulmonol. 2013 Aug 16. [QxMD MEDLINE Link].

31. Pouwels S, de Boer A, Leufkens HG, Weber WE, Cooper C, van Onzenoort HA, et al. Risk of fracture in patients with muscular dystrophies. Osteoporos Int. 2013 Aug 15. [QxMD MEDLINE Link].

32. Duan D. Myodys, a full-length dystrophin plasmid vector for Duchenne and Becker muscular dystrophy gene therapy. Curr Opin Mol Ther. 2008 Feb. 10(1):86-94. [QxMD MEDLINE Link].

33. Bowles DE, McPhee SW, Li C, Gray SJ, Samulski JJ, Camp AS, et al. Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector. Mol Ther. 2011 Nov 8. [QxMD MEDLINE Link].

Benjamin R Mandac, MD Chief of Physical Medicine and Rehabilitation, Medical Director of Pediatric Rehabilitation, Kaiser Permanente at Santa Clara

Benjamin R Mandac, MD is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Physical Medicine and Rehabilitation

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Kat Kolaski, MD Assistant Professor, Departments of Orthopedic Surgery and Pediatrics, Wake Forest University School of Medicine

Kat Kolaski, MD is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Physical Medicine and Rehabilitation

Disclosure: Nothing to disclose.

Stephen Kishner, MD, MHA Clinical Professor, Louisiana State University School of Medicine in New Orleans

Stephen Kishner, MD, MHA is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine

Disclosure: Nothing to disclose.

Elizabeth A Moberg-Wolff, MD Medical Director, Pediatric Rehabilitation Medicine Associates

Elizabeth A Moberg-Wolff, MD is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Physical Medicine and Rehabilitation

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article